Half-year report · HY
4465.TEDINET S100XFH2
Period2025-06-01 → 2025-11-30
Filed2026-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.1bn | 2025-06-01 → 2025-11-30 | Cons. | Net sales |
| Revenue | ¥23.7bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.7bn | 2024-06-01 → 2024-11-30 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2025-06-01 → 2025-11-30 | Cons. | Operating income |
| Operating income | ¥879m | 2024-06-01 → 2024-11-30 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2025-06-01 → 2025-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥906m | 2024-06-01 → 2024-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.3bn | 2025-06-01 → 2025-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥906m | 2024-06-01 → 2024-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥912m | 2025-06-01 → 2025-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥608m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥912m | 2025-06-01 → 2025-11-30 | Cons. | Profit loss |
| Net income | ¥608m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss |
| Total assets | ¥23.8bn | at 2025-11-30 | Cons. | Assets |
| Total assets | ¥22.6bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥23.3bn | at 2024-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.2bn | at 2025-11-30 | Cons. | Liabilities |
| Total liabilities | ¥7.8bn | at 2025-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.6bn | at 2025-11-30 | Cons. | Net assets |
| Net assets / equity | ¥14.8bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.8bn | at 2024-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.3bn | at 2025-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.8bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.9bn | at 2025-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.3bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2024-05-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥310m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥76m | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥420m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥358m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥573m | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥946m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥425m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥154.31 | 2025-06-01 → 2025-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥305.84 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥103.03 | 2024-06-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 65.7% | at 2025-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.3% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.4% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| Chemical Businessreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥11.5bn |
| Chemical Businessreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥11.5bn |
| Chemical Businessreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥996m |
| Healthcare Businessreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥673m |
| Healthcare Businessreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥673m |
| Healthcare Businessreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥148m |
| —segment total | revenue | 2025-06-01 → 2025-11-30 | ¥12.1bn |
| —segment total | revenue external | 2025-06-01 → 2025-11-30 | ¥12.1bn |
| —segment total | segment profit | 2025-06-01 → 2025-11-30 | ¥1.1bn |
| Chemical Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥11.0bn |
| Chemical Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥11.0bn |
| Chemical Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥731m |
| Healthcare Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥671m |
| Healthcare Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥671m |
| Healthcare Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥148m |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥11.7bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥11.7bn |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥879m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 476
| Item | Context | Value | Unit |
|---|---|---|---|
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | InterimDuration | Text · Plus | |
| Notes accounting treatments specific to semi annual financial statements type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | InterimDuration | Text · Plus | |
| Notes business combinations semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |